Kanaph Therapeutics is a biotechnology company that develops novel therapeutics for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 11-50
Address: 3, Itaewon-ro 55 ga-gil,
City: Yongsan-gu
State: seoul teugbyeolsi
Zip: 04348
Country: KR
Kanaph Therapeutics is a biotechnology company that develops novel therapeutics for the treatment of cancer.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2019 | Series A | 2 | $6M |
Meritz Securities Time Folio Asset Management Meritz Securities Time Folio Asset Management |
10/2020 | Series B | $0 |
Green Cross Kolon Investment Time Folio Asset Management Green Cross Kolon Investment Time Folio Asset Management |
10/2020 | Series B | 3 | $21M |
GC Pharma Kolon Investment Timefolio Asset Management Green Cross Kolon Investment Time Folio Asset Management |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|